HF
DARE icon

HRT Financial’s Dare Bioscience DARE Stock Holding History

HRT Financial’s Portfolio DARE Stock Details DARE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-10,497
Closed -$20K – 3961
2025
Q4 		$20K Buy
+10,497
New +$20.9K ﹤0.01% 2981
2022
Q4 		– Sell
-1,147
Closed -$13K – 2579
2022
Q3 		$13K Buy
+1,147
New +$15.8K ﹤0.01% 2516
2022
Q1 		– Sell
-4,032
Closed -$96K – 3241
2021
Q4 		$96K Buy
+4,032
New +$82.9K ﹤0.01% 2771

Other funds holding DARE

VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
US Bancorp
US Bancorp Minneapolis, Minnesota $82.4B AUM 19.69% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

HRT Financial's DARE Position: Q1 2026 in Review

HRT Financial sold out of Dare Bioscience (DARE) in Q1 2026, closing a stake of 10,497 shares — an estimated $20K sold.

HRT Financial first reported a position in DARE in Q4 2021 and held it in 3 quarters. The position peaked at $96K in Q4 2021. 25 funds tracked by Wall St. Rank hold DARE as of Q1 2026.

  • HRT Financial reported no remaining Dare Bioscience position as of Q1 2026 after selling out during the quarter.
  • HRT Financial sold 10,497 Dare Bioscience shares in Q1 2026, an estimated $20K.
  • HRT Financial first reported a position in Dare Bioscience in Q4 2021 and held it in 3 quarters.
  • HRT Financial's Dare Bioscience position peaked at $96K in Q4 2021.
  • 25 funds tracked by Wall St. Rank held Dare Bioscience as of Q1 2026.

Based on HRT Financial's 13F filing for Q1 2026, filed 14 May 2026.